Skip to content

Clinical research on phage therapy for refractory bacterial infections

Clinical research on phage therapy for refractory bacterial infections

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101886
Enrollment
Unknown
Registered
2025-04-30
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection with multi-drug resistant bacteria

Interventions

Bacteriophage treatment group:Phage therapy

Sponsors

The Second Affiliated Hospital of Hainan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with multi-drug resistant bacterial infections; 2. The pathogenic bacteria causing the infection of the patients should meet one of the following conditions: 1) The pathogenic bacteria are fully resistant to antibiotics; 2) They are resistant to key antibiotics; 3) The pathogenic bacteria are sensitive to key antibiotics in vitro but the treatment with such antibiotics is ineffective or has no obvious effect; 4) The use of key sensitive antibiotics for the pathogenic bacteria is restricted; 3. At least one lytic bacteriophage can be screened out; 4. The administration can be carried out through spraying on the infection site, external application, nebulization inhalation, perfusion, local injection or administration through drainage tubes; 5. The subjects and their families (or guardians) have fully read, understood and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Bacterial infections can be effectively controlled by antibiotics; 2. There is no other route of administration except intravenous injection; 3. Patients who, as determined by the researchers, are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Significantly inhibit, reduce or eliminate pathogenic bacteria;

Countries

China

Contacts

Public ContactYi Wang

The Second Affiliated Hospital of Hainan Medical University

wayne0108@126.com+86 139 0734 0108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026